We found that the CD27+ cell content in the CD19+CD24highCD38high tBregs cells was significantly reduced in the MS patients (1.0% ± 0.5%) as compared with healthy individuals (2.2% ± 1.4%). Here, CD19 is linked to myeloid sarcoma.